Investigation of localized delivery of diclofenac sodium from poly(D,L-lactic acid-co-glycolic acid)/poly(ethylene glycol) scaffolds using an in vitro osteoblast inflammation model

Tissue Engineering - Part A

Volumn 21, Issue 1-2, 2015, Pages 362-373

  Sidney, Laura E ^a   Heathman, Thomas R J ^a   Britchford, Emily R ^a   Abed, Arif ^a   Rahman, Cheryl V ^a   Buttery, Lee D K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELLS; COPOLYMERS; CYTOLOGY; ETHYLENE; ETHYLENE GLYCOL; GLYCOPROTEINS; LACTIC ACID; NITRIC OXIDE; OSTEOBLASTS; PATHOLOGY; POLYETHYLENE GLYCOLS; POLYOLS; SINTERING; SODIUM; TISSUE; TISSUE ENGINEERING;

ANTI-INFLAMMATORY DRUGS; BONE TISSUE ENGINEERING; FOREIGN BODY RESPONSE; OPTIMAL CONCENTRATION; OSTEOCHONDRAL TISSUE ENGINEERING; POLY(D ,L-LACTIC ACID-CO-GLYCOLIC ACID); PROINFLAMMATORY CYTOKINES; TUMOR NECROSIS FACTORS;

SCAFFOLDS (BIOLOGY);

CADHERIN; CADHERIN 11; COLLAGEN TYPE 1; DICLOFENAC; GAMMA INTERFERON; INTERLEUKIN 1BETA; MACROGOL; NITRIC OXIDE; OSTEOCALCIN; OSTEOPONTIN; POLYGLACTIN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MACROGOL DERIVATIVE; POLY(LACTIC-GLYCOLIC ACID)-POLY(ETHYLENEGLYCOL) COPOLYMER; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BONE TISSUE; CALVARIA; CELL COUNT; CELL DEATH; CELL DENSITY; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FOREIGN BODY REACTION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SCANNING ELECTRON MICROSCOPY; STEADY STATE; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; PATHOLOGY; SKULL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DICLOFENAC; DINOPROSTONE; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-1BETA; MICE; MODELS, BIOLOGICAL; NITRIC OXIDE; OSTEOBLASTS; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; SKULL; TISSUE SCAFFOLDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921415333     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2014.0100     Document Type: Article

References (55)

1. McKibbin, B. The biology of fracture healing in long bones. J Bone Joint Surg Br 60-B, 150, 1978.
2. Schaffer, M., and Barbul, A. Lymphocyte function in wound healing and following injury. Br J Surg 85, 444, 1998.
3. Gerstenfeld, L.C., Cullinane, D.M., Barnes, G.L., Graves, D.T., and Einhorn, T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88, 873, 2003.
4. Rundle, C.H., Wang, H., Yu, H., Chadwick, R.B., Davis, E.I., Wergedal, J.E., Lau, K.H., Mohan, S., Ryaby, J.T., and Baylink, D.J. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone 38, 521, 2006.
5. Kon, T., Cho, T.J., Aizawa, T., Yamazaki, M., Nooh, N., Graves, D., Gerstenfeld, L.C., and Einhorn, T.A. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cyto-kines during fracture healing. J Bone Miner Res 16, 1004, 2001.
6. Cho, T.J., Gerstenfeld, L.C., and Einhorn, T.A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17, 513, 2002.
7. Barnes, G.L., Kostenuik, P.J., Gerstenfeld, L.C., and Ein-horn, T.A. Growth factor regulation of fracture repair. J Bone Miner Res 14, 1805, 1999.
8. Mountziaris, P.M., and Mikos, A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14, 179, 2008.
9. Bostman, O., and Pihlajamaki, H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials 21, 2615, 2000.
10. Mourino, V., and Boccaccini, A.R. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface 7, 209, 2010.
11. Corry, D., and Moran, J. Assessment of acrylic bone cement as a local delivery vehicle for the application of non-steroidal anti-inflammatory drugs. Biomaterials 19, 1395, 1998.
12. Rainsford, K.D. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Am J Med 107, 27S, 1999.
13. Dhillon, A., Schneider, P., Kuhn, G., Reinwald, Y., White, L., Levchuk, A., Rose, F., Müller, R., Shakesheff, K., and Rahman, C. Analysis of sintered polymer scaffolds using concomitant synchrotron computed tomography and in situ mechanical testing. J Mater Sci Mater Med 22, 2599, 2011.
14. Rahman, C.V., Ben-David, D., Dhillon, A., Kuhn, G., Gould, T.W., Muller, R., Rose, F.R., Shakesheff, K.M., and Livne, E. Controlled release of BMP-2 from a sintered polymer scaffold enhances bone repair in a mouse calvarial defect model. J Tissue Eng Regen Med 8, 59, 2012.
15. Rahman, C.V., Kuhn, G., White, L.J., Kirby, G.T., Varghese, O.P., McLaren, J.S., Cox, H.C., Rose, F.R., Muller, R., Hilborn, J., and Shakesheff, K.M. PLGA/PEG-hydrogel composite scaffolds with controllable mechanical properties. J Biomed Mater Res B Appl Biomater 101, 648, 2013.
16. Gould, T.W., Birchall, J.P., Mallick, A.S., Alliston, T., Lustig, L.R., Shakesheff, K.M., and Rahman, C.V. Development of a porous poly(DL-lactic acid-co-glycolic acid)-based scaffold for mastoid air-cell regeneration. Laryngoscope 123, 3156, 2013.
17. Rahman, C.V., Smith, S.J., Morgan, P.S., Langmack, K.A., Clarke, P.A., Ritchie, A.A., Macarthur, D.C., Rose, F.R., Shakesheff, K.M., Grundy, R.G., and Ruman, R. Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix. PLoS One 8, e77435, 2013.
18. Hickey, T., Kreutzer, D., Burgess, D.J., and Moussy, F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res 61, 180, 2002.
19. Khaled, K., Sarhan, H.A., Ibrahim, M.A., Ali, A.H., and Naguib, Y.W. Prednisolone-loaded PLGA microspheres. In vitro characterization and in vivo application in adjuvant-induced arthritis in mice. AAPS PharmSciTech 11, 859, 2010.
20. Willoughby, D., and Winyard, P.G. Inflammation protocols. In: Walker, J., ed. Methods in Molecular Biology. Totowa, NJ: Humana Press, 2003.
21. Huuskonen, J., Suuronen, T., Miettinen, R., van Groen, T., and Salminen, A. A refined in vitro model to study inflammatory responses in organotypic membrane culture of postnatal rat hippocampal slices. J Neuroinflammation 2, 25, 2005.
22. Olinga, P., Merema, M.T., de Jager, M.H., Derks, F., Melgert, B.N., Moshage, H., Slooff, M.J., Meijer, D.K., Poelstra, K., and Groothuis, G.M. Rat liver slices as a tool to study LPS-induced inflammatory response in the liver. J Hepatol 35, 187, 2001.
23. Smith, E.L., Locke, M., Waddington, R.J., and Sloan, A.J. An ex vivo rodent mandible culture model for bone repair. Tissue Eng Part C Methods 16, 1287, 2010.
24. Hughes, F.J., Buttery, L.D., Hukkanen, M.V., O'Donnell, A., Maclouf, J., and Polak, J.M. Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and-independent mechanism in rat osteoblasts in vitro. J Biol Chem 274, 1776, 1999.
25. Akatsu, T., Takahashi, N., Udagawa, N., Imamura, K., Yamaguchi, A., Sato, K., Nagata, N., and Suda, T. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 6, 183, 1991.
26. Nikkola, L., Seppala, J., Harlin, A., Ndreu, A., and Ashammakhi, N. Electrospun multifunctional diclofenac sodium releasing nanoscaffold. J Nanosci Nanotechnol 6, 3290, 2006.
27. Tunçay, M., Calixs, S., Kaxs, H.S., Ercan, M.T., Peksoy, I., and Hincal, A.A. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int J Pharm 195, 179, 2000.
28. Attama, A.A., Reichl, S., and Muller-Goymann, C.C. Di-clofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm 355, 307, 2008.
29. Sidney, L.E., Kirkham, G.R., and Buttery, L.D. Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1beta, TNF-Alpha, and IFN-gamma. Stem Cells Dev 23, 605, 2014.
30. Vane, J.R., and Botting, R.M. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 104, 2S, 1998.
31. Mitchell, J.A., Akarasereenont, P., Thiemermann, C., Flower, R.J., and Vane, J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90, 11693, 1993.
32. Willoughby, D., and Tomlinson, A. Inducible enzymes in the inflammatory response. In: Parnham, M., ed. Progress in Inflammation Research. 1st ed. Basel: Birkhauser Ver-lag, 1999, pp. 211.
33. Kolar, P., Schmidt-Bleek, K., Schell, H., Gaber, T., Toben, D., Schmidmaier, G., Perka, C., Buttgereit, F., and Duda, G.N. The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev 16, 427, 2010.
34. Martin, P., Souza, D.D., Martin, J., Grose, R., Cooper, L., Maki, R., McKercher, S.R., Fields, I., Wca, L., and Jolla, L. Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 13, 1122, 2003.
35. Toben, D., Schroeder, I., El Khassawna, T., Mehta, M., Hoffmann, J.E., Frisch, J.T., Schell, H., Lienau, J., Serra, A., Radbruch, A., and Duda, G.N. Fracture healing is accelerated in the absence of the adaptive immune system. J Bone Miner Res 26, 113, 2011.
36. Martinez, F.O., Sica, A., Mantovani, A., and Locati, M. Macrophage activation and polarization. Front Biosci 13, 453, 2008.
37. Duffield, J.S. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Lond) 104, 27, 2003.
38. Marsolais, D., Cote, C.H., and Frenette, J. Nonsteroidal anti-inflammatory drug reduces neutrophil and macrophage accumulation but does not improve tendon regeneration. Lab Invest 83, 991, 2003.
39. Na, Y.R., Yoon, Y.N., Son, D.I., and Seok, S.H. Cy-clooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model. PLoS One 8, e63451, 2013.
40. Simon, A.M., Manigrasso, M.B., and O'Connor, J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17, 963, 2002.
41. Zhang, X., Schwarz, E.M., Young, D.A., Puzas, J.E., Rosier, R.N., and O'Keefe, R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109, 1405, 2002.
42. Krischak, G.D., Augat, P., Blakytny, R., Claes, L., Kinzl, L., and Beck, A. The non-steroidal anti-inflammatory drug diclofenac reduces appearance of osteoblasts in bone defect healing in rats. Arch Orthop Trauma Surg 127, 453, 2007.
43. Aeberhard, E.E., Henderson, S.A., Arabolos, N.S., Grisca-vage, J.M., Castro, F.E., Barrett, C.T., and Ignarro, L.J. Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 208, 1053, 1995.
44. Amin, A.R., Vyas, P., Attur, M., Leszczynska-Piziak, J., Patel, I.R., Weissmann, G., and Abramson, S.B. The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA 92, 7926, 1995.
45. Kepka-Lenhart, D., Chen, L.C., and Morris, S.M., Jr. Novel actions of aspirin and sodium salicylate: discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line. J Leu-koc Biol 59, 840, 1996.
46. Salvemini, D., Manning, P.T., Zweifel, B.S., Seibert, K., Connor, J., Currie, M.G., Needleman, P., and Masferrer, J.L. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96, 301, 1995.
47. Kanematsu, M., Ikeda, K., and Yamada, Y. Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells. J Bone Miner Res 12, 1789, 1997.
48. Tetsuka, T., Daphna-Iken, D., Srivastava, S.K., Baier, L.D., DuMaine, J., and Morrison, A.R. Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci USA 91, 12168, 1994.
49. Salvemini, D., Settle, S.L., Masferrer, J.L., Seibert, K., Currie, M.G., and Needleman, P. Regulation of prosta-glandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 114, 1171, 1995.
50. Cantón, I., McKean, R., Charnley, M., Blackwood, K.A., Fiorica, C., Ryan, A.J., and MacNeil, S. Development of an Ibuprofen-releasing biodegradable PLA/PGA electrospun scaffold for tissue regeneration. Biotechnol Bioeng 105, 396, 2010.
51. Della Porta, G., Falco, N., and Reverchon, E. NSAID drugs release from injectable microspheres produced by supercritical fluid emulsion extraction. J Pharm Sci 99, 1484, 2010.
52. Kang, Y., Wu, J., Yin, G., Huang, Z., Yao, Y., Liao, X., Chen, A., Pu, X., and Liao, L. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Eur J Pharm Biopharm 70, 85, 2008.
53. Ju, Y.M., Yu, B.Z., West, L., Moussy, Y., and Moussy, F. A dexamethasone-loaded PLGA micirospheres/collagen scaffold composite for implantable glucose sensors. J Biomed Mater Res 93A, 200, 2010.
54. Chang, J.K., Li, C.J., Liao, H.J., Wang, C.K., Wang, G.J., and Ho, M.L. Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-Apoptotic factors in cultured human osteoblasts. Toxicology 258, 148, 2009.
55. Chang, J.K., Li, C.J., Wu, S.C., Yeh, C.H., Chen, C.H., Fu, Y.C., Wang, G.J., and Ho, M.L. Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochem Pharmacol 74, 1371, 2007.